Cargando…

In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach

Limited progress has been made in the quest to identify both selective and non-toxic T-type calcium channel blocking compounds. The present research work was directed toward slaking the same by identifying the selective three dimensional (3D) pharmacophore map for T-type calcium channel blockers (CC...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandhi, Tamanna, Melge, Anu R., Gopi Mohan, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045570/
https://www.ncbi.nlm.nih.gov/pubmed/27713840
http://dx.doi.org/10.1016/j.jare.2016.09.004
_version_ 1782457142073098240
author Gandhi, Tamanna
Melge, Anu R.
Gopi Mohan, C.
author_facet Gandhi, Tamanna
Melge, Anu R.
Gopi Mohan, C.
author_sort Gandhi, Tamanna
collection PubMed
description Limited progress has been made in the quest to identify both selective and non-toxic T-type calcium channel blocking compounds. The present research work was directed toward slaking the same by identifying the selective three dimensional (3D) pharmacophore map for T-type calcium channel blockers (CCBs). Using HipHop module in the CATALYST 4.10 software, both selective and non-selective HipHop pharmacophore maps for T-type CCBs were developed to identify its important common pharmacophoric features. HipHop pharmacophore map of the selective T-type CCBs contained six different chemical features, namely ring aromatic (R), positive ionizable (P), two hydrophobic aromatic (Y), hydrophobic aliphatic (Z), hydrogen bond acceptor (H) and hydrogen bond donor (D). However, non-selective T-type CCBs contain all the above mentioned features except ring aromatic (R). The present ligand-based pharmacophore mapping approach could thus be utilized in classifying selective vs. non-selective T-type CCBs. Further, the model can be used for virtual screening of several small molecule databases.
format Online
Article
Text
id pubmed-5045570
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-50455702016-10-06 In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach Gandhi, Tamanna Melge, Anu R. Gopi Mohan, C. J Adv Res Original Article Limited progress has been made in the quest to identify both selective and non-toxic T-type calcium channel blocking compounds. The present research work was directed toward slaking the same by identifying the selective three dimensional (3D) pharmacophore map for T-type calcium channel blockers (CCBs). Using HipHop module in the CATALYST 4.10 software, both selective and non-selective HipHop pharmacophore maps for T-type CCBs were developed to identify its important common pharmacophoric features. HipHop pharmacophore map of the selective T-type CCBs contained six different chemical features, namely ring aromatic (R), positive ionizable (P), two hydrophobic aromatic (Y), hydrophobic aliphatic (Z), hydrogen bond acceptor (H) and hydrogen bond donor (D). However, non-selective T-type CCBs contain all the above mentioned features except ring aromatic (R). The present ligand-based pharmacophore mapping approach could thus be utilized in classifying selective vs. non-selective T-type CCBs. Further, the model can be used for virtual screening of several small molecule databases. Elsevier 2016-11 2016-09-16 /pmc/articles/PMC5045570/ /pubmed/27713840 http://dx.doi.org/10.1016/j.jare.2016.09.004 Text en © 2016 Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Gandhi, Tamanna
Melge, Anu R.
Gopi Mohan, C.
In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach
title In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach
title_full In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach
title_fullStr In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach
title_full_unstemmed In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach
title_short In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach
title_sort in silico identification of t-type calcium channel blockers: a ligand-based pharmacophore mapping approach
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045570/
https://www.ncbi.nlm.nih.gov/pubmed/27713840
http://dx.doi.org/10.1016/j.jare.2016.09.004
work_keys_str_mv AT gandhitamanna insilicoidentificationofttypecalciumchannelblockersaligandbasedpharmacophoremappingapproach
AT melgeanur insilicoidentificationofttypecalciumchannelblockersaligandbasedpharmacophoremappingapproach
AT gopimohanc insilicoidentificationofttypecalciumchannelblockersaligandbasedpharmacophoremappingapproach